Investigator

Lene Hjerrild Iversen

Aalborg University

Research Interests

LHILene Hjerrild Ive…
Papers(1)
Assessment of periton…
Collaborators(3)
Mette Schou MikkelsenEdvard MarinovskijJan Blaakaer
Institutions(2)
Aarhus UniversitySDU

Papers

Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer

Preoperative assessment of peritoneal metastases is an important factor for treatment planning and selection of candidates for cytoreductive surgery (CRS) in primary advanced stage (FIGO stages III-IV) epithelial ovarian cancer (EOC). The primary aim was to evaluate the efficacy of DW-MRI, CT, and FDG PET/CT used for preoperative assessment of peritoneal cancer index (PCI). In this prospective observational cohort study, 50 advanced stage EOC patients were examined with DW-MRI and FDG PET/CT with contrast enhanced CT as part of the diagnostic program. All patients were deemed amenable for upfront CRS. Imaging PCI was determined for DW-MRI, CT, and FDG PET/CT by separate readers blinded to the surgical findings. The primary outcome was agreement between the imaging PCI and PCI determined at surgical exploration (the reference standard) evaluated with Bland-Altman statistics. The median surgical PCI was 18 (range: 3-32). For all three imaging modalities, the imaging PCI most often underestimated the surgical PCI. The mean differences between the surgical PCI and the imaging PCI were 4.2 (95% CI: 2.6-5.8) for CT, 4.4 (95% CI: 2.9-5.8) for DW-MRI, and 5.3 (95% CI: 3.6-7.0) for FDG PET/CT, and no overall statistically significant differences were found between the imaging modalities (DW-MRI - CT, p = 0.83; DW-MRI - FDG PET/CT, p = 0.24; CT - FDG PET/CT, p = 0.06). Neither DW-MRI nor CT nor FDG PET/CT was superior in preoperative assessment of the surgical PCI in patients scheduled for upfront CRS for advanced stage EOC.

240Works
1Papers
3Collaborators
Colorectal NeoplasmsPrognosisCirculating Tumor DNARectal NeoplasmsColonic NeoplasmsBiomarkers, TumorNeoplasm Staging

Positions

Researcher

Aalborg University

2025–

DVIP-external, External VIP

Aarhus University · Department of Clinical Medicine - Department of Clinical Epidemiology

2025–

Professor, consultant surgeon

Aalborg University Hospital · Department of Gastrointestinal Surgery

2025–

Clinical professor

Aalborg University · Department of Clinical Medicine

2024–

VIP, Professor

Aarhus University · Department of Clinical Medicine

2024–

Professor

Aarhus University · Department of Clinical Medicine

2015–

Clinical professor

Aarhus University · Department of Clinical Medicine

2002–

Professor, consultant surgeon

Aarhus University Hospital

Education

1990

MD

Aarhus University

Country

DK